The aim of this work was to characterise the diffusive properties of superabsorbent polymer systems prepared by free radical crosslinking polymerisation of acrylic acid. The polyelectrolyte nature of these hydrogels gives rise to high swelling capacities, and their ability to absorb and retain water is highly dependent on the precise network structure. Modifying the synthesis formulation results in considerable changes to the dynamic and structural properties of these gels, providing the motive for the work presented here. The influence of two factors, namely the extent of monomer neutralisation and the level of crosslinker in the pre-gel solution, were investigated. The dynamic properties of gels were examined using Quasi-Elastic Light Scattering (QELS), from which the cooperative diffusion coefficient and degree of heterogeneity could be determined. The former was found to increase linearly with neutralisation, due to the introduction of electrostatic interactions. The diffusion coefficient initially remained constant with the addition of crosslinker, due to the dominating influence of physical entanglements, but increased above a threshold crosslinking degree, corresponding to a reduction of the network mesh size. The extent of large-scale inhomogeneity increased for higher ionisations, as both the crosslinker solubility and the efficiency of monomer-crosslinker reaction decreased. However, there was a tendency for concentration fluctuations to be minimised for higher neutralisations, making the gel more microscopically homogeneous. Kinetics of swelling experiments were used to investigate gels of varying composition. The macroscopic diffusion coefficient was found to increase rapidly with increasing neutralisation until the monomer was approximately 35% neutralised, beyond which point counterion condensation caused insignificant variation. This trend was also reflected in the equilibrium swelling ratios, and mode of diffusion. For the majority of gels, the diffusion process was characterised as case II transport. Variation of crosslinking degree caused an overall increase in the diffusion coefficient, reflecting the trend observed in the QELS studies. Nuclear Reaction Analysis (NRA) was used to probe the penetration of heavy water into dry network slabs. The concentration-depth profiles revealed a discontinuity in the diffusion coefficient, corresponding to the transition between glassy and rubbery states, for which the diffusivities differed by several orders of magnitude. The kinetics of plasticisation was assumed to be the rate determining factor in the swelling process, on the timescale of the NRA experiments. The diffusion coefficient for the swollen rubbery region, representative of the macroscopic diffusion process, was found to increase linearly with neutralisation, and decrease with crosslinking degree. The latter observation was explained as due to a reduction in the free volume available for solvent diffusion with higher levels of crosslinker.

No description available.

No description available.

Dielectric elastomers are electroactive polymers, which change size and shape in response to an electrical field. Dielectric elastomer actuators (DEAs) are highly promising new technologies in optical applications such as tuneable optical lenses, diffraction gratings and active camouflage. This thesis aims to develop a new approach to create a strain actuated compliant colour changing device that is controlled using DEAs as they offer stretchability, low weight, high efficiency, low cost and the possibility for miniaturisation. Conventional DEAs use transparent elastomeric materials with no significant colour change with strain. Conversely, liquid crystal materials are known to display dynamic colour changing behaviour, thereby making them good candidate materials. The thesis examines both the potential for colour changing soft actuators and the upcoming challenges in this field as well as the key concepts around liquid crystals that exhibit colour change. An initial approach was aimed at creating colour changes using dielectric elastomer actuators that drove a masked positioner. This method showed colour change since the mask changes the colour visualisation. The second approach used polymer dispersed liquid crystals, such as a nematic liquid crystal within a reactive silicone resin. The immiscibility of these compounds resulted in a dispersion of the liquid crystal droplets in the silicone matrix. However, the optical properties could not be controlled through mechanical deformation alone and the alignment of resulting LC droplets in the PDLC films was sensitive to the substrate used to perform the actuation. The next approach used reactive cholesteric liquid crystals (CLC) instead. A thin film coating process was preferred to carefully control the film's thickness by stretching. In free standing films a planar cholesteric alignment was obtained with mesogens aligned parallel to the substrate and colour was achieved based on the selective reflection of light. A transfer print technique was introduced to combine CLC coatings with elastomeric substrates that can be stretched. However, no colour change was achieved in response to mechanical deformation primarily due to the modulus and strength mismatch between the thin film and the elastomeric susbstrate material. Finally, lightly crosslinked liquid crystal elastomers using a combination of reactive and non-reactive liquid crystals were produced that were compatible with elastomer substrate materials. In free standing films planar cholesteric alignment was obtained with mesogens aligned parallel to the substrate. Successfully a reversible colour change based on selective reflection of light was achieved in response to a mechanical deformation.

Nanoscale colloidal particles display fascinating electronic, optical and reinforcement properties as a consequence of their dimensions. Stable dispersions of nanoscale colloids find applications in drug delivery, biodiagnostics, photonic and electronic devices, and polymer nanocomposites. Most nanoparticles are unstable in dispersions and polymeric surfactants are added generally to improve dispersability and control self-assembly. However, the effect of polymeric modifiers on nanocolloid properties is poorly understood and design of modifiers is guided usually by empirical approaches. Monte Carlo simulations are used to gain a fundamental molecular-level understanding of the effect of modifiers properties on the thermodynamics and interaction forces of nanoscale colloidal particles. A novel method based on the expanded ensemble Monte Carlo technique has been developed for calculation of the chemical potential of colloidal particles in colloid-polymer mixtures (CPM). Using this method, the effect of molecular parameters like colloid diameter, polymer chain length, colloid-polymer interaction strength, and colloid and polymer concentrations, on the colloid chemical potential is investigated for both hard-sphere and attractive Lennard-Jones CPM. The presence of short-chain polymeric modifiers reduces the colloid chemical potential in attractive as well as athermal systems. In attractive CPM, there is a strong correlation between polymer adsorption and colloid chemical potential, as both show a similar dependence on the polymer molecular weight. Based on the simulation results, simple scaling relationships are proposed that capture the functional dependence of the thermodynamic properties on the molecular parameters. The polymer-induced interaction forces between the nanoparticles have been calculated as a function of the above parameters for freely-adsorbing and end-grafted homopolymer modifiers. The polymer-induced force profiles are used to identify design criteria for effective modifiers. Adsorbing modifiers give rise to attractive interactions between the nanoparticles over the whole parameter range explored in this study. Grafted surface modifiers lead to attraction or repulsion based on the polymer chain length and grafting density. The polymer-induced attraction in both adsorbing and grafted modifiers is attributed primarily to polymer intersegmental interactions and bridging. The location of the thermodynamic minimum corresponding to the equilibrium particle spacing in nanoparticle-polymer mixtures can be controlled by tuning the modifier properties.

A esquistossomose é uma doença parasitária aguda e crônica causada por vermes sanguíneos (vermes nematoides) do gênero Schistosoma. O homem contrai a esquistossomose através da penetração ativa da cercaria na pele. A importância do tratamento desta enfermidade consiste não só no fato de curar a doença ou diminuir a carga parasitária dos pacientes, bem como impedir sua evolução para formas mais graves. Para o tratamento da esquistossomose o fármaco de escolha é o praziquantel; isso se deve ao seu amplo espectro, sua eficácia, segurança e a relação custo/tratamento. A única forma farmacêutica disponível no Brasil é o comprimido, na dose de 600 mg, a qual pode ser subdividida em quatro partes de 150 mg, a fim de facilitar o ajuste de dose. No entanto, no momento da subdivisão dos comprimidos ocorre o rompimento do revestimento. Este fato acaba levando a uma exposição do fármaco e, consequentemente, de seu sabor amargo. Esta característica dificulta a administração do medicamento, principalmente na população infantil, prejudicando o tratamento e o controle da doença. Uma alternativa para este problema é o desenvolvimento de sistemas poliméricos microparticulados que associados ao fármaco impediriam o contato direto com as papilas gustativas e assim promoveriam uma melhoria na palatabilidade. Para isso utilizou-se a técnica modificada de deposição interfacial do polímero pré-formado seguido de secagem por aspersão. Três matrizes poliméricas, com diferentes características de liberação foram utilizadas, Eudragit RL 100 – liberação tempo dependente e Eudragit E100 e L30D-55 – liberação pH dependente. Além disso, dois tipos de sistemas carreadores do fármaco foram preparados, microcápsulas e microesferas poliméricas. Estes sistemas obtidos foram avaliados e caracterizados a fim de eleger a melhor proposta de formulação visando o mascaramento do sabor do fármaco. De acordo com os resultados obtidos selecionou-se um sistema composto por microcápsulas formadas a partir do polímero L30D-55. A partir de então inseriu-se este sistema na forma farmacêutica pó para suspensão oral, onde diferentes propostas de formulações, contendo dois edulcorantes auxiliares, aspartame e sacarina, separadamente, e seus respectivos placebos foram avaliadas através de um método in vitro para a determinação do sabor, a língua eletrônica ou sensor gustativo. As diferentes formulações avaliadas apresentaram capacidade em mascarar o sabor desagradável do fármaco e, assim resultam em uma promissora alternativa para o aumento da adesão por parte dos pacientes à terapêutica, principalmente para crianças, em virtude da facilidade de administração, do ajuste da dose em função da massa corpórea e ao sabor muito mais agradável ao paladar infantil. / Schistosomiasis is a parasitic disease acute and chronic caused by blood worms (nematodes worms) of the genus Schistosoma. Man acquires schistosomiasis through the active penetration of the worms in skin. The importance of treatment of this disease is not only the fact of curing the disease or decreases the parasite load of patients, well as prevent progression to more severe forms. For the treatment of schistosomiasis praziquantel is the drug of choice, this is due to its wide spectrum, its efficacy, safety and the relation cost / treatment. The single dosage form available in Brazil is tablet at a dose of 600 mg, which can be subdivided into four parts of 150 mg to facilitate dose adjustment. However when the subdivision of the tablets occurs the disruption of the coating. This fact provides a drug exposure and consequently of its bitter taste. This characteristic complicates the administration of the drug mainly in children, affecting the treatment and control of disease. An alternative for this problem is the development of microparticulate polymeric systems which associated with the drug would prevent direct contact with the taste buds and thus promote an improvement in palatability. For this was used a modified technique interfacial deposition of preformed polymer followed by spray drying. Three polymer matrices with different release characteristics have been used, Eudragit RL 100 – time dependent release, and Eudragit E100 and L30D-55 – pH dependent release. Furthermore, two types of drug carrier systems have been prepared, polymeric microspheres and microcapsules. These systems obtained were evaluated and characterized in order to select the best proposal formulation aimed at masking the taste of the drug. According to the results we selected a system comprising microcapsules formed from L30D-55 polymer. From then was inserted into this system in the pharmaceutical form, powder for oral suspension, where different proposals formulations containing two auxiliary sweeteners, aspartame and saccharin, separately, and their respective placebos were evaluated in an in vitro method for determining the taste, the electronic tongue. The different formulations tested presented excellent ability to mask the unpleasant taste of the drug and thus present an excellent alternative for increasing adherence to therapy, especially for children, because of the ease of administration, according on dose adjustment of body mass and the much more palatable to children's taste.

A esquistossomose é uma doença parasitária aguda e crônica causada por vermes sanguíneos (vermes nematoides) do gênero Schistosoma. O homem contrai a esquistossomose através da penetração ativa da cercaria na pele. A importância do tratamento desta enfermidade consiste não só no fato de curar a doença ou diminuir a carga parasitária dos pacientes, bem como impedir sua evolução para formas mais graves. Para o tratamento da esquistossomose o fármaco de escolha é o praziquantel; isso se deve ao seu amplo espectro, sua eficácia, segurança e a relação custo/tratamento. A única forma farmacêutica disponível no Brasil é o comprimido, na dose de 600 mg, a qual pode ser subdividida em quatro partes de 150 mg, a fim de facilitar o ajuste de dose. No entanto, no momento da subdivisão dos comprimidos ocorre o rompimento do revestimento. Este fato acaba levando a uma exposição do fármaco e, consequentemente, de seu sabor amargo. Esta característica dificulta a administração do medicamento, principalmente na população infantil, prejudicando o tratamento e o controle da doença. Uma alternativa para este problema é o desenvolvimento de sistemas poliméricos microparticulados que associados ao fármaco impediriam o contato direto com as papilas gustativas e assim promoveriam uma melhoria na palatabilidade. Para isso utilizou-se a técnica modificada de deposição interfacial do polímero pré-formado seguido de secagem por aspersão. Três matrizes poliméricas, com diferentes características de liberação foram utilizadas, Eudragit RL 100 – liberação tempo dependente e Eudragit E100 e L30D-55 – liberação pH dependente. Além disso, dois tipos de sistemas carreadores do fármaco foram preparados, microcápsulas e microesferas poliméricas. Estes sistemas obtidos foram avaliados e caracterizados a fim de eleger a melhor proposta de formulação visando o mascaramento do sabor do fármaco. De acordo com os resultados obtidos selecionou-se um sistema composto por microcápsulas formadas a partir do polímero L30D-55. A partir de então inseriu-se este sistema na forma farmacêutica pó para suspensão oral, onde diferentes propostas de formulações, contendo dois edulcorantes auxiliares, aspartame e sacarina, separadamente, e seus respectivos placebos foram avaliadas através de um método in vitro para a determinação do sabor, a língua eletrônica ou sensor gustativo. As diferentes formulações avaliadas apresentaram capacidade em mascarar o sabor desagradável do fármaco e, assim resultam em uma promissora alternativa para o aumento da adesão por parte dos pacientes à terapêutica, principalmente para crianças, em virtude da facilidade de administração, do ajuste da dose em função da massa corpórea e ao sabor muito mais agradável ao paladar infantil. / Schistosomiasis is a parasitic disease acute and chronic caused by blood worms (nematodes worms) of the genus Schistosoma. Man acquires schistosomiasis through the active penetration of the worms in skin. The importance of treatment of this disease is not only the fact of curing the disease or decreases the parasite load of patients, well as prevent progression to more severe forms. For the treatment of schistosomiasis praziquantel is the drug of choice, this is due to its wide spectrum, its efficacy, safety and the relation cost / treatment. The single dosage form available in Brazil is tablet at a dose of 600 mg, which can be subdivided into four parts of 150 mg to facilitate dose adjustment. However when the subdivision of the tablets occurs the disruption of the coating. This fact provides a drug exposure and consequently of its bitter taste. This characteristic complicates the administration of the drug mainly in children, affecting the treatment and control of disease. An alternative for this problem is the development of microparticulate polymeric systems which associated with the drug would prevent direct contact with the taste buds and thus promote an improvement in palatability. For this was used a modified technique interfacial deposition of preformed polymer followed by spray drying. Three polymer matrices with different release characteristics have been used, Eudragit RL 100 – time dependent release, and Eudragit E100 and L30D-55 – pH dependent release. Furthermore, two types of drug carrier systems have been prepared, polymeric microspheres and microcapsules. These systems obtained were evaluated and characterized in order to select the best proposal formulation aimed at masking the taste of the drug. According to the results we selected a system comprising microcapsules formed from L30D-55 polymer. From then was inserted into this system in the pharmaceutical form, powder for oral suspension, where different proposals formulations containing two auxiliary sweeteners, aspartame and saccharin, separately, and their respective placebos were evaluated in an in vitro method for determining the taste, the electronic tongue. The different formulations tested presented excellent ability to mask the unpleasant taste of the drug and thus present an excellent alternative for increasing adherence to therapy, especially for children, because of the ease of administration, according on dose adjustment of body mass and the much more palatable to children's taste.

A esquistossomose é uma doença parasitária aguda e crônica causada por vermes sanguíneos (vermes nematoides) do gênero Schistosoma. O homem contrai a esquistossomose através da penetração ativa da cercaria na pele. A importância do tratamento desta enfermidade consiste não só no fato de curar a doença ou diminuir a carga parasitária dos pacientes, bem como impedir sua evolução para formas mais graves. Para o tratamento da esquistossomose o fármaco de escolha é o praziquantel; isso se deve ao seu amplo espectro, sua eficácia, segurança e a relação custo/tratamento. A única forma farmacêutica disponível no Brasil é o comprimido, na dose de 600 mg, a qual pode ser subdividida em quatro partes de 150 mg, a fim de facilitar o ajuste de dose. No entanto, no momento da subdivisão dos comprimidos ocorre o rompimento do revestimento. Este fato acaba levando a uma exposição do fármaco e, consequentemente, de seu sabor amargo. Esta característica dificulta a administração do medicamento, principalmente na população infantil, prejudicando o tratamento e o controle da doença. Uma alternativa para este problema é o desenvolvimento de sistemas poliméricos microparticulados que associados ao fármaco impediriam o contato direto com as papilas gustativas e assim promoveriam uma melhoria na palatabilidade. Para isso utilizou-se a técnica modificada de deposição interfacial do polímero pré-formado seguido de secagem por aspersão. Três matrizes poliméricas, com diferentes características de liberação foram utilizadas, Eudragit RL 100 – liberação tempo dependente e Eudragit E100 e L30D-55 – liberação pH dependente. Além disso, dois tipos de sistemas carreadores do fármaco foram preparados, microcápsulas e microesferas poliméricas. Estes sistemas obtidos foram avaliados e caracterizados a fim de eleger a melhor proposta de formulação visando o mascaramento do sabor do fármaco. De acordo com os resultados obtidos selecionou-se um sistema composto por microcápsulas formadas a partir do polímero L30D-55. A partir de então inseriu-se este sistema na forma farmacêutica pó para suspensão oral, onde diferentes propostas de formulações, contendo dois edulcorantes auxiliares, aspartame e sacarina, separadamente, e seus respectivos placebos foram avaliadas através de um método in vitro para a determinação do sabor, a língua eletrônica ou sensor gustativo. As diferentes formulações avaliadas apresentaram capacidade em mascarar o sabor desagradável do fármaco e, assim resultam em uma promissora alternativa para o aumento da adesão por parte dos pacientes à terapêutica, principalmente para crianças, em virtude da facilidade de administração, do ajuste da dose em função da massa corpórea e ao sabor muito mais agradável ao paladar infantil. / Schistosomiasis is a parasitic disease acute and chronic caused by blood worms (nematodes worms) of the genus Schistosoma. Man acquires schistosomiasis through the active penetration of the worms in skin. The importance of treatment of this disease is not only the fact of curing the disease or decreases the parasite load of patients, well as prevent progression to more severe forms. For the treatment of schistosomiasis praziquantel is the drug of choice, this is due to its wide spectrum, its efficacy, safety and the relation cost / treatment. The single dosage form available in Brazil is tablet at a dose of 600 mg, which can be subdivided into four parts of 150 mg to facilitate dose adjustment. However when the subdivision of the tablets occurs the disruption of the coating. This fact provides a drug exposure and consequently of its bitter taste. This characteristic complicates the administration of the drug mainly in children, affecting the treatment and control of disease. An alternative for this problem is the development of microparticulate polymeric systems which associated with the drug would prevent direct contact with the taste buds and thus promote an improvement in palatability. For this was used a modified technique interfacial deposition of preformed polymer followed by spray drying. Three polymer matrices with different release characteristics have been used, Eudragit RL 100 – time dependent release, and Eudragit E100 and L30D-55 – pH dependent release. Furthermore, two types of drug carrier systems have been prepared, polymeric microspheres and microcapsules. These systems obtained were evaluated and characterized in order to select the best proposal formulation aimed at masking the taste of the drug. According to the results we selected a system comprising microcapsules formed from L30D-55 polymer. From then was inserted into this system in the pharmaceutical form, powder for oral suspension, where different proposals formulations containing two auxiliary sweeteners, aspartame and saccharin, separately, and their respective placebos were evaluated in an in vitro method for determining the taste, the electronic tongue. The different formulations tested presented excellent ability to mask the unpleasant taste of the drug and thus present an excellent alternative for increasing adherence to therapy, especially for children, because of the ease of administration, according on dose adjustment of body mass and the much more palatable to children's taste.

The phase behavior of CO2 + polymer systems is of interest in polymer synthesis, flue and natural gas processing, polymer foam and nanoparticle processing, and drug delivery. Theoretical and experimental evidence suggests that CO2 is able to interact with electron donating functional groups in polymers to form weak Lewis acid – base or EDA (Electron Donor Acceptor) complexes. These complexes can have a significant effect on the phase behavior of associated CO2 + polymer systems. In spite of this, however, the phase equilibria of only a few associated CO2 + polymer systems have been measured. Some success in modeling the phase behavior of polymer solutions has been achieved by various versions of the Statistical Association Fluid Theory (SAFT), as well as by several Lattice Models. However, many of these models incorporate two to four adjustable parameters that often depend on temperature (T), pressure (P), and/or molecular weight (MW). As a result, a large amount of experimental data is required to apply these models. The goal of the present work was therefore to develop a new thermodynamic model for associating systems that would include no more than two temperature-independent adjustable parameters. The new model presented in this work is based on the Guggenheim-Huggins-Miller lattice and includes complex formation in the development of the partition function. The EOS obtained from the resulting partition function includes two mixture parameters – the enthalpy of association or complex formation and a reference value of the equilibrium constant for complex formation . Most importantly, can be obtained from in situ Attenuated Total Reflection Fourier Transform Infrared (ATR – FTIR) measurements. This work therefore demonstrates the use of ATR – FTIR spectra to obtain molecular level information regarding the interaction of CO2 and electron donating functional groups in polymers. Unlike other studies, this work uses the bending vibration of CO2 to estimate the enthalpies of association ( ) of CO2 + polymer systems. Values of were directly incorporated in the new model and were found to lie between -7 and -12 kJ/mol for the systems investigated in this work. They increased (i.e. became more negative) in the order: CO2 + PS-co-PMMA < CO2 + PMMA <CO2 + PBMA < CO2 + PSF < CO2 + PVAc < CO2 + EVA40 < CO2 + PEG. Values of the second parameter in the new EOS ( ) were obtained by fitting solubility data at one temperature. Both and were found to be temperature independent. The application of the new EOS was demonstrated by calculating the solubility (sorption) of CO2 in polymers, the extent of swelling of polymers due to CO2, and the solubility of polymers in CO2 (cloud points). Both sorption and cloud point behavior in CO2 + polymer systems could be calculated using a single value of for each binary system. Ionic Liquids (ILs) can also incorporate electron donating functional groups in their structure. Evidence for the interaction of such ILs with CO2 can be found in the large values of the enthalpies of absorption of CO2 in these ILs. The ALF EOS was therefore extended to CO2 + IL systems using the enthalpy of absorption as a measure of association ( ) in these systems. was again treated as an adjustable parameter in the calculation of the CO2 solubility in ILs. A single value of was sufficient to predict swelling in these systems within experimental error.

The potential applications of dispersed and self-assembled nanoparticles depend critically on accurate control and prediction of their phase behavior. The chemical potential is essential in describing the equilibrium distribution of all components present in every phase of a system and is useful as a building block for constructing phase diagrams. Furthermore, the chemical potential is a sensitive indicator of the local environment of a molecule or particle and is defined in a mathematically rigorous manner in both classical and statistical thermodynamics. The goal of this research is to use simulations and experiments to understand how particle size and composition affect the particle chemical potential of attractive nanoparticle-polymer mixtures. The expanded ensemble Monte Carlo (EEMC) simulation method for the calculation of the particle chemical potential for a nanocolloid in a freely adsorbing polymer solution is extended to concentrated polymer mixtures. The dependence of the particle chemical potential and polymer adsorption on the polymer concentration and particle diameter are presented. The perturbed Lennard-Jones chain (PLJC) equation of state (EOS) for polymer chains1 is adapted to calculate the particle chemical potential of nanocolloid-polymer mixtures. The adapted PLJC equation is able to predict the EEMC simulation results of the particle chemical potential by introducing an additional parameter that reduces the effects of polymer adsorption and the effective size of the colloidal particle. Osmotic pressure measurements are used to calculate the chemical potential of nanocolloidal silica in an aqueous poly(ethylene oxide) (PEO) solution at different silica and PEO concentrations. The experimental data was compared with results calculated from Expanded Ensemble Monte Carlo (EEMC) simulations. The results agree qualitatively with the experimentally observed chemical potential trends and illustrate the experimentally-observed dependence of the chemical potential on the composition. Furthermore, as is the case with the EEMC simulations, polymer adsorption was found to play the most significant role in determining the chemical potential trends. The simulation and experimental results illustrate the relative importance of the particles size and composition as well as the polymer concentration on the particle chemical potential. Furthermore, a method for using osmometry to measure chemical potential of nanoparticles in a nanocolloid-mixture is presented that could be combined with simulation and theoretical efforts to develop accurate equations of state and phase behavior predictions. Finally, an equation of state originally developed for polymer liquid-liquid equilibria (LLE) was demonstrated to be effective in predicting nanoparticle chemical potential behavior observed in the EEMC simulations of particle-polymer mixtures.